ABELINA MALDONADO: Open Payments
NPI 1396212791 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 14 payments from 6 companies in 2025. Trend: 2023 $569 · 2024 $1,988 · 2025 $994
Food & beverage: $994
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $233 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $203 |
| ABBVIE INC. | 4 | $151 |
| Axsome Therapeutics, Inc. | 3 | $145 |
| Neurocrine BioSciences, Inc. | 2 | $140 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
Products named: COBENFY, CAPLYTA, VRAYLAR, Auvelity, INGREZZA, UZEDY.
Industry payments across MD — which companies pay providers there.
